Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Money symbols : Jnj save search
Johnson & Johnson Reports Q1 2024 Results
Published: 2024-04-16 (Crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
results
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
Published: 2024-04-16 (Crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
year
$4.9B Vertex-Alpine Deal Highlights Continued 2024 M&A Upswing
Published: 2024-04-11 (Crawled : 15:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
deal
American Lung Association and LUNGevity Foundation Announce $3 Million Research Partnership to Intercept Lung Cancer
Published: 2024-04-09 (Crawled : 11:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
partnership lung association million cancer research foundation
Merck, Genmab, Kintara and More Continue 2024 M&A Upswing
Published: 2024-04-08 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
Contineum Therapeutics Announces Pricing of Initial Public Offering - April 05, 2024
Published: 2024-04-05 (Crawled : 09:00) - biospace.com/
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Genmab, Kintara, Ginkgo and More Continue 2024 M&A Upswing
Published: 2024-04-03 (Crawled : 14:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
2024 M&A Upswing Continues With Avalo, Gilead, Immunome Buys
Published: 2024-03-29 (Crawled : 16:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
2024 M&A Upswing Continues With Gilead, Immunome, Novo Buys
Published: 2024-03-28 (Crawled : 16:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
Capstan Secures $175M Oversubscribed Series B with Backing from J&J, Bayer an...
Published: 2024-03-21 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
series
Capstan Therapeutics Announces $175M Oversubscribed Series B Financing
Published: 2024-03-20 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.35%
H: 0.4%
C: 0.36%
series therapeutics
BMS Closing of $14B Karuna Purchase Highlights 2024 M&A Upswing
Published: 2024-03-18 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
BMS, AstraZeneca, Novartis Add to 2024 M&A Upswing
Published: 2024-03-18 (Crawled : 15:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
novartis
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
Published: 2024-03-15 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
series
Novartis, Merck, J&J Add to 2024 M&A Upswing
Published: 2024-03-14 (Crawled : 14:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
Merck, J&J Add to 2024 M&A Upswing
Published: 2024-03-12 (Crawled : 12:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
LEGN | $47.16 -3.42% -3.54% 820K
|
Health Technology
|
| O: 1.08%
H: 3.77%
C: 1.97%
biotech year results
J&J Adds to 2024 M&A Upswing
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
Opinion: 2024 Will Be a Buyers’ Market in Biopharma. It Already Is.
Published: 2024-02-21 (Crawled : 06:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
market
Vanda Buys US, Canadian Rights to J&J’s MS Drug Ponvory in $100M Deal
Published: 2023-12-08 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
SNY | News | $45.41 -1.52% 4.3M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
drug ponvory deal
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
ZCMD | $2.44 78.1% 43.85% 330K
|
Commercial Services
XPON | $3.1 60.62% 37.74% 16M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.